The Prospect Medical Holdings bankruptcy is many things at once: a cautionary tale about private equity’s role in healthcare, a regulatory failure story, and — for the attorneys who represent patients harmed at Prospect facilities — an object lesson in what happens when a hospital chain that self-insured its malpractice liability never actually set aside the money to pay claims.
Prospect, which grew from a small California company to a 17-hospital chain across six states through debt-fueled acquisitions, filed for Chapter 11 bankruptcy in January 2025. An April 2026 ProPublica investigation revealed that the company, which had promised to cover malpractice defense and settlements for its hospitals and affiliated physicians up to $7.5 million per case, had set aside essentially nothing for those obligations. Hundreds of pending malpractice claims — involving patients who allege they were harmed by dangerous care, poor infection control, and understaffed facilities — now face the prospect of recovering little or nothing through the bankruptcy process.
Prospect is not alone. The same pattern has emerged in the bankruptcies of Steward Health Care — once the largest private for-profit hospital system in the United States — and Genesis HealthCare, formerly the nation’s largest nursing home company. Genesis agreed to at least 155 malpractice settlements totaling $58 million but filed for bankruptcy before paying most plaintiffs. The problem, as Connecticut Rep. Cristin McCarthy Vahey put it, is a “gaping hole” in oversight of self-insured healthcare entities.
The specific legal dynamics attorneys need to understand:
Self-insurance versus commercial insurance. When a healthcare company self-insures, there is no third-party insurer standing behind the claim. States typically require commercial insurers to maintain solvency reserves and contribute to guaranty funds that protect claimants if an insurer fails. Self-insured entities face no equivalent backstop. Rhode Island acknowledged that Prospect had not filed required financial disclosures since 2019 — and took no enforcement action.
Bankruptcy stay and claims priority. Once a company files for Chapter 11, an automatic stay halts all litigation against the debtor. Malpractice claims become unsecured creditor claims — among the last to be paid in bankruptcy proceedings, behind secured lenders, administrative costs, and priority claims. The practical effect for plaintiffs is that even valid, well-documented claims may yield cents on the dollar.
Pursuing individual physicians. When the hospital entity is in bankruptcy, attorneys are looking at whether individual physicians have personal malpractice coverage independent of the institutional policy. For physicians employed by Prospect who relied on the hospital’s self-insurance promise, that question has produced genuinely alarming answers: at least some are now facing personal liability exposure with no institutional defense funding.
Corporate parent liability. The Prospect collapse has renewed focus on whether private equity sponsors — who extracted substantial returns before the bankruptcy — can be held liable through theories of alter ego, fraudulent transfer, or successor liability. Those claims are complex and jurisdiction-dependent, but they are being actively litigated.
For plaintiff’s attorneys with cases at Prospect, Steward, or any private-equity-backed healthcare facility, the Prospect situation is a warning about case timing and insurance verification. Understanding whether a hospital is commercially insured or self-insured — and the financial health of that self-insurance arrangement — is now a due diligence step that cannot be skipped at intake.
References
- Elkind P. “Prospect Medical Never Put Aside Money for Malpractice Insurance.” ProPublica / CT Mirror. April 9, 2026.
- Private Equity Stakeholder Project. “Private Equity Healthcare Bankruptcies Are on the Rise.” 2025.
- U.S. Senate Budget Committee. “Profits Over Patients.” January 2025.
- KFF Health News. “Genesis HealthCare Bankruptcy and Malpractice Settlements.” 2024.
